The increased expression of miR-214 is involved in cisplatin resistance in ovarian cancer by down-regulation of PTEN protein and activation of the PI3K/AKT/mTOR pathway, thereby enhancing cell survival.58 Here, AKT1 is linked to ovarian cancer.